Share on StockTwits
 

Illumina (NASDAQ:ILMN) CFO Marc Stapley sold 20,038 shares of the stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $151.32, for a total value of $3,032,150.16. Following the sale, the chief financial officer now directly owns 21,797 shares of the company’s stock, valued at approximately $3,298,322. The sale was disclosed in a legal filing with the SEC, which is available at this link.

A number of analysts have recently weighed in on ILMN shares. Analysts at Leerink Swann set a $160.00 price target on shares of Illumina in a research note to investors on Wednesday, January 29th. Separately, analysts at Mizuho raised their price target on shares of Illumina from $150.00 to $175.00 in a research note to investors on Wednesday, January 29th. They now have a “buy” rating on the stock. Finally, analysts at ISI Group raised their price target on shares of Illumina from $134.50 to $147.00 in a research note to investors on Wednesday, January 29th. They now have a “neutral” rating on the stock. Six equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $117.24.

Shares of Illumina (NASDAQ:ILMN) traded down 0.65% on Monday, hitting $151.01. 1,923,627 shares of the company’s stock traded hands. Illumina has a 52 week low of $48.00 and a 52 week high of $154.99. The stock’s 50-day moving average is $122.1 and its 200-day moving average is $94.49. The company has a market cap of $19.134 billion and a P/E ratio of 168.89.

Illumina (NASDAQ:ILMN) last announced its earnings results on Tuesday, January 28th. The company reported $0.45 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.44 by $0.01. The company had revenue of $387.00 million for the quarter, compared to the consensus estimate of $382.06 million. During the same quarter in the prior year, the company posted $0.42 earnings per share. The company’s quarterly revenue was up 25.1% on a year-over-year basis. On average, analysts predict that Illumina will post $2.07 earnings per share for the current fiscal year.

Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.